Mackenzie Financial
SRNE

Mackenzie Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Mackenzie Financial’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,219
Closed -$22.3K – 1642
2022
Q4 		$22.3K Hold
25,219
– – ﹤0.01% 1397
2022
Q3 		$40K Sell
25,219
-811
-3% -$1.84K ﹤0.01% 1372
2022
Q2 		$52K Buy
26,030
+8,900
+52% +$15.4K ﹤0.01% 1395
2022
Q1 		$40K Buy
17,130
+2,024
+13% +$6.31K ﹤0.01% 1379
2021
Q4 		$70K Sell
15,106
-851
-5% -$5.28K ﹤0.01% 1383
2021
Q3 		$122K Buy
+15,957
New +$135K ﹤0.01% 1362

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return